| A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) | Phase II | rekrutiert |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Ma | Phase III | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of | Phase II | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Ge | Phase II | rekrutiert |
| A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) | — | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | Phase II | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab P | Phase I | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, a | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propi | Phase III | rekrutiert |
| A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglob | — | rekrutiert |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With A | — | rekrutiert |
| A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to | Phase IV | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple | Phase I / Phase II | rekrutiert |
| A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe | Phase II / Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | — | rekrutiert |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With | — | rekrutiert |
| A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treat | — | rekrutiert |
| A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in P | Phase III | rekrutiert |
| A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platin | Phase II | rekrutiert |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Diseas | Phase II | rekrutiert |
| A Study of BGB-11417 in Participants With Myeloid Malignancies | Phase I / Phase II | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D | Phase II | rekrutiert |
| A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Tr | Phase II | rekrutiert |
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | Phase I / Phase II | rekrutiert |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Phase I / Phase II | rekrutiert |
| A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase II | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase III | rekrutiert |
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulc | Phase II | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal S | Phase III | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic | Phase II | rekrutiert |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose | Phase II | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection Af | — | rekrutiert |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tum | Phase I / Phase II | rekrutiert |
| A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome | Phase II | rekrutiert |
| A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Re | Phase III | rekrutiert |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Phase III | rekrutiert |
| A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ | — | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NP | Phase I / Phase II | rekrutiert |
| A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pem | Phase III | rekrutiert |
| A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surg | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-AD | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refr | Phase I / Phase II | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan ( | Phase III | rekrutiert |
| A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Re | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Car | Phase III | rekrutiert |
| A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participant | Phase III | rekrutiert |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 | Phase III | rekrutiert |
| A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chroni | Phase II | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sep | Phase II | rekrutiert |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Part | Phase II | rekrutiert |
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Partic | Phase I | rekrutiert |
| A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria | Phase II | rekrutiert |
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Neph | Phase III | rekrutiert |
| A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has | Phase II / Phase III | rekrutiert |
| A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Ed | Phase II | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalid | Phase III | rekrutiert |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atr | Phase II | rekrutiert |
| A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients W | Phase I / Phase II | rekrutiert |
| AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Ex | Phase III | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Abbott Vascular Medical Device Registry | — | rekrutiert |
| Acotec DCB Post Market Clinical Follow-up | — | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry | — | rekrutiert |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA | Phase II / Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | — | rekrutiert |
| An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study of AZD0120 in Adults With Multiple Sclerosis | Phase I | rekrutiert |
| Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Oc | Phase IV | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data | ohne Phasenangabe | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacin | ohne Phasenangabe | rekrutiert |
| Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With | Phase II | rekrutiert |
| Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | ohne Phasenangabe | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CRP Apheresis in STEMI | ohne Phasenangabe | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Cardiac Amyloidosis Registry of University Hospital Leipzig | — | rekrutiert |
| CeraFlex PFO Closure System PMCF Study | — | rekrutiert |
| Cerebellar Mutism Syndrome Study | — | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent | ohne Phasenangabe | rekrutiert |
| Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tu | Phase I / Phase II | rekrutiert |
| Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations | Phase II | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ES | Phase II / Phase III | rekrutiert |
| Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck | ohne Phasenangabe | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses | ohne Phasenangabe | rekrutiert |
| Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Fe | ohne Phasenangabe | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transca | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Corheart 6 LVAS Study | ohne Phasenangabe | rekrutiert |
| CrescNet - Growth Monitoring Network | — | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis | ohne Phasenangabe | rekrutiert |
| DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrol | Phase III | rekrutiert |
| Delayed Against Rapid Sequence Induction in Adults With Medical Diseases Undergoing Emergency En | ohne Phasenangabe | rekrutiert |
| Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmon | Phase III | rekrutiert |
| Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstructi | ohne Phasenangabe | rekrutiert |
| Diagnostic Criteria in Cardiac Sarcoidosis | — | rekrutiert |
| Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostat | Phase III | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN | ohne Phasenangabe | rekrutiert |
| EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpe | Phase II | rekrutiert |
| EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn | ohne Phasenangabe | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Early Detection and IntervenTion in Heart Failure | ohne Phasenangabe | rekrutiert |
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SG | Phase III | rekrutiert |
| Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiova | — | rekrutiert |
| Effects of a 6-months Fiber- and Polyphenol-rich Diet on Brain Inflammatory Processes in Perimen | ohne Phasenangabe | rekrutiert |
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS | Phase III | rekrutiert |
| Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Poly | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain an | Phase III | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Pred | Phase II | rekrutiert |
| Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight- | Phase III | rekrutiert |
| Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged | Phase III | rekrutiert |
| Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HF | Phase II | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do N | Phase II | rekrutiert |
| Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monog | — | rekrutiert |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | ohne Phasenangabe | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia | Phase III | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical De | — | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Pat | Phase III | rekrutiert |
| Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Me | Phase II / Phase III | rekrutiert |
| Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the | Phase II | rekrutiert |
| Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Mo | ohne Phasenangabe | rekrutiert |
| Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF | ohne Phasenangabe | rekrutiert |
| Eye Diseases "Treated" With Interoperable Medical Informatics | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Tra | ohne Phasenangabe | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| HRS-AKI Treatment With TIPS in Patients With Cirrhosis | ohne Phasenangabe | rekrutiert |
| Harmony TPV EMEA PMS | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Impact of Microbiome-changing Interventions on Food Decision-making | ohne Phasenangabe | rekrutiert |
| Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) | ohne Phasenangabe | rekrutiert |
| Intermittent Fasting to Improve Insulin Secretion | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| International Wilson's Disease Patient Registry (iWilson Registry) | — | rekrutiert |
| Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dy | Phase II | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating | Phase III | rekrutiert |
| LANDMARK Trial: a Randomised Controlled Trial of Myval THV | ohne Phasenangabe | rekrutiert |
| LEOPARD Training and Validation Data Collection Study | — | rekrutiert |
| LIFE Child (LIFE Leipzig Research Centre for Civilization Diseases) | — | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |